[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582223":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":33,"responsibleParty":121,"collaborators":10,"id":123,"slug":10,"hasResults":124,"nctId":125,"briefTitle":126,"officialTitle":127,"acronym":10,"eligibilityCriteria":128,"healthyVolunteers":124,"sex":129,"minAge":130,"maxAge":131,"enrollmentInfo":132,"targetDuration":10,"studyType":135,"phases":10,"briefSummary":136,"conditions":137,"keywords":10,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":147,"locationsCount":148},{"fullName":5,"class":6},"GentiBio, Inc","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"all participants",null,"aged ≥ 18 to ≤ 55 years recently (within 6 months of the study visit) diagnosed with T1D",[13],"Other: blood draw or cheek swab",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","blood draw or cheek swab","a blood draw or cheek swab for testing of HLA-DRB1\\*04:01",[9],[21],{"name":22,"affiliation":5,"role":23},"Mark Bach, MD","STUDY_DIRECTOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Kristin M Neff, MS","CONTACT","85-732-75483","kristin.neff@gentibio.com",{"name":22,"role":27,"phone":31,"phoneExt":10,"email":32},"908-578-3634","mark.bach@gentibio.com",[34,55,72,89,104],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"University of California, San Francisco","RECRUITING","San Francisco","California","94158","United States",{"type":42,"coordinates":43},"Point",[44,45],-122.41942,37.77493,{"lat":45,"lon":44},[48,52],{"name":49,"role":27,"phone":50,"phoneExt":10,"email":51},"Rebecca Wesch, Recruitment Coordinator","844-813-8273","clinicalresearch@diabetes.ucsf.edu",{"name":53,"role":54,"phone":10,"phoneExt":10,"email":10},"Stephen Gitelman, MD","PRINCIPAL_INVESTIGATOR",{"facility":56,"status":36,"city":57,"state":58,"zip":59,"country":40,"cosmosGeoPoint":60,"geoPoint":64,"contacts":65},"University of Florida- Gainesville","Gainesville","Florida","32610",{"type":42,"coordinates":61},[62,63],-82.32483,29.65163,{"lat":63,"lon":62},[66,70],{"name":67,"role":27,"phone":68,"phoneExt":10,"email":69},"Jennifer Hosford","352-294-5759","jennifer.hosford@peds.ufl.edu",{"name":71,"role":54,"phone":10,"phoneExt":10,"email":10},"Michael Haller, MD",{"facility":73,"status":36,"city":74,"state":75,"zip":76,"country":40,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Joslin Diabetes Center","Boston","Massachusetts","02215",{"type":42,"coordinates":78},[79,80],-71.05977,42.35843,{"lat":80,"lon":79},[83,87],{"name":84,"role":27,"phone":85,"phoneExt":10,"email":86},"Michelle Zhang","888-813-8669","T1DTrials@joslin.harvard.edu",{"name":88,"role":54,"phone":10,"phoneExt":10,"email":10},"Jason Gaglia, MD",{"facility":90,"status":36,"city":91,"state":91,"zip":92,"country":40,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"Icahn School of Medicine at Mount Sinai","New York","10029",{"type":42,"coordinates":94},[95,96],-74.00597,40.71427,{"lat":96,"lon":95},[99,103],{"name":100,"role":27,"phone":101,"phoneExt":10,"email":102},"Carol Levy, MD","212-241-0068","carol.levy@mssm.edu",{"name":100,"role":54,"phone":10,"phoneExt":10,"email":10},{"facility":105,"status":36,"city":106,"state":107,"zip":108,"country":40,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"University of North Carolina at Chapel Hill","Chapel Hill","North Carolina","27514",{"type":42,"coordinates":110},[111,112],-79.05584,35.9132,{"lat":112,"lon":111},[115,119],{"name":116,"role":27,"phone":117,"phoneExt":10,"email":118},"Alex Kass","984-974-3004","uncdiabetes@med.unc.edu",{"name":120,"role":54,"phone":10,"phoneExt":10,"email":10},"Klara Klein, MD",{"type":122,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100582223",false,"NCT06860516","HLA Demographics Study in Adults With Type 1 Diabetes","A Non-interventional Study of HLA-DRB1*04:01 Distribution in Adults With Recently Diagnosed Type 1 Diabetes (T1D)","Inclusion Criteria:\n\n1. Male and female participants aged ≥ 18 to ≤ 55 years, with type 1 DM meeting American Diabetes Association criteria at diagnosis:\n\n   1. Fasting glucose ≥ 126 mg\u002FdL (7.0 mmol\u002FL), or\n   2. 2-hour oral glucose tolerance test plasma glucose ≥ 200 mg\u002FdL (11.0 mmol\u002FL), or\n   3. Hemoglobin A1c ≥ 6.5%, or\n   4. Random plasma glucose ≥ 200 mg\u002FdL (11.1 mmol\u002FL) (with documented classic hyperglycemia symptoms or hyperglycemic crisis).\n2. Date of T1D diagnosis within 6 months of the study visit.\n3. Able and willing to provide written, informed consent as approved by the institutional review board (IRB). Participants must be able to consent directly; no other person or guardian may consent for them in this study.\n\nExclusion Criteria:\n\n1. Participant is an employee of, or an immediate family member of an employee, of the Sponsor, study site, or of a contractor\u002Fvendor who is involved in direct study conduct for this protocol.\n2. Participant is unwilling or unable to comply with the study visit assessments.","ALL","18 Years","55 Years",{"count":133,"type":134},200,"ESTIMATED","OBSERVATIONAL","This is a study to evaluate the HLA-DRB1\\*04:01 genotype in adults that have been diagnosed with type 1 diabetes",[138],"Diabetes Mellitus, Type I","2026-04-30",{"date":141,"type":142},"2026-05-06","ACTUAL",{"date":144,"type":142},"2025-06-06",{"date":146,"type":134},"2027-03",{"name":5,"class":6},5]